8-K: USPH Reports Strong 2025 Growth, Eyes 2026 Hospital Alliances

U.S. Physical Therapy, Inc. delivered robust financial performance in 2025 with significant EBITDA and revenue growth, driven by record patient visits and strategic acquisitions, while setting the stage for accelerated expansion through new hospital affiliations in 2026 and beyond.

Summary

• Adjusted EBITDA for the full year 2025 increased by $13.2 million, a 16.2% improvement over the prior year, reaching $95 million.
• Net revenue for 2025 grew by 16.3%, with the physical therapy business up 16% and injury prevention businesses up 18%.
• The company achieved record annual average visits per clinic per day of 32.2 in 2025, and a record 32.7 for the fourth quarter.
• Total patient visits increased 11.2% year-over-year, including a 1.5% increase at mature clinics for the full year, accelerating to 2.6% in Q4.
• Net rate per patient visit increased 1% for the full year 2025 to $105.76, and 1.7% in Q4 2025 to $106.49, despite Medicare rate reductions.
• Two significant long-term hospital affiliation arrangements were announced, expected to begin phasing in mid-2026 and contribute at least $14 million in enterprise EBITDA by 2027, with USPH's portion being over $7 million after minority interest.
• Strategic initiatives for 2026 include ambient listening documentation support, semi-virtualization of front desk operations, cash-based program expansion, remote therapeutic monitoring, and continued de novo and acquisition development.
• The company is implementing a new enterprise-wide financial and human resources system, with a go-live target of January 1, 2027, incurring $600,000 in implementation costs in Q4 2025.

Sentiment

Score: 9

Explanation: StockSavvy.ai views this filing as highly positive, reflecting strong financial performance, effective navigation of industry headwinds, and clear strategic initiatives that promise accelerated growth and margin expansion in the coming years, particularly through new hospital affiliations.

Positives

• Adjusted EBITDA increased by $13.2 million (16.2%) for the full year 2025, reaching $95 million, demonstrating strong profitability growth.
• Net revenue grew by 16.3% for the full year 2025, indicating robust top-line expansion across both physical therapy and injury prevention segments.
• Record-high average visits per clinic per day were achieved for both the full year (32.2) and the fourth quarter (32.7), reflecting strong demand and operational efficiency.
• Net rate per patient visit increased by 1% for the full year and 1.7% in Q4 2025, demonstrating effective rate management despite Medicare rate reductions.
• Physical therapy adjusted gross margin improved by almost 200 basis points in Q4 2025 to 20.5%, showcasing enhanced cost discipline and profitability.
• Injury prevention income grew by 11.5% organically in Q4 2025 and 20.2% for the full year, highlighting strong performance in this segment.
• Two significant long-term hospital affiliations are expected to provide an enterprise lift of at least $14 million in EBITDA by 2027, with USPH's share exceeding $7 million, promising substantial future growth.
• The balance sheet remains strong with $35.6 million in cash, a $131 million term loan at a fixed rate of 4.77% through mid-2027, and a $175 million revolving credit facility with only $30.5 million drawn.

Negatives

• GAAP EPS can be counterintuitively reduced when partnerships perform well due to the revaluation of non-controlling interest, which increases redeemable non-controlling interest.
• The injury prevention segment experienced a sequential decline in gross margin in Q4 due to staffing up for new large contracts ahead of revenue generation and typical year-end seasonality with manufacturing shutdowns.

Risks

• Continued Medicare rate reductions were a headwind in 2025, though the company anticipates closing that chapter in 2026 with a modest rate increase.
• The inflationary environment poses a challenge to managing operating costs, although the company demonstrated effective cost control in 2025.
• The revaluation of non-controlling interest can negatively impact GAAP EPS, making financial performance appear worse despite actual operational improvements.

Future Outlook

U.S. Physical Therapy, Inc. expects adjusted EBITDA for 2026 to be in the range of $102 million to $106 million, which includes $2.5 million in incremental revenue from the January 1, 2026 Medicare rate increase. The company anticipates significant contributions from two new hospital affiliation agreements, which will begin phasing in mid-2026 and are projected to contribute at least $14 million to PT revenue and income, with USPH's portion of adjusted EBITDA being at least $7.3 million, once fully implemented by year-end 2026 for the 2027 fiscal year. The company also projects a 2.5% to 3% increase in same-store revenues (visits and rates combined) for 2026, with non-Medicare pricing expected to be 1.5% to 2% positive.

Management Comments

• Chris Reading, Chairman and CEO, stated, "These results, which our team feels very good about, were delivered in an environment in 2025 with continued Medicare rate reductions, and in spite of that, across every measure, we delivered progress and a very good year overall."
• Chris Reading highlighted the strategic hospital arrangements, noting, "These are very long-term arrangements, which will further improve our patient reach in these important markets, and will positively impact volume, margins, growth opportunities, along with care access as well."
• Chris Reading emphasized the role of therapists: "Our therapists, and all therapists, should be recognized as musculoskeletal experts -the primary care providers of musculoskeletal treatment, who every day deliver complex restorative care at an unbelievable and unmatched value."
• Carey Hendrickson, Chief Financial Officer, remarked, "2025 was an excellent year for USPH from really every standpoint and particularly from a financial standpoint. Importantly, the efforts we made on key initiatives in 2025... set USPH up for even greater growth and financial results in 2026 and beyond."
• Carey Hendrickson noted the strong volume, "Our average visits per clinic per day in the fourth quarter was 32.7. That's the highest fourth quarter volume per clinic per day in our company's history. It's actually seven consecutive quarters that we've had a record number of visits on a per day basis."

Industry Context

StockSavvy.ai notes that U.S. Physical Therapy's strong performance and strategic focus on hospital affiliations align with broader healthcare trends towards integrated care networks and the outsourcing of specialized services by larger hospital systems. The emphasis on musculoskeletal expertise positions the company well within a growing demand for value-based care and preventative services, particularly as healthcare systems seek to optimize patient pathways and improve outcomes. The expansion into diverse injury prevention services, including specialized testing for infrastructure projects, demonstrates an adaptive strategy to capture growth in adjacent, high-margin segments beyond traditional physical therapy.

Stakeholder Impact

• Shareholders: Expected to benefit from strong financial performance, increased profitability, and accelerated growth from strategic initiatives and hospital affiliations, potentially leading to increased share value.
• Employees (Clinicians & Staff): Continued demand and expansion may lead to job security and growth opportunities, with initiatives like ambient listening and front desk virtualization potentially impacting workflows and efficiency.
• Patients: Improved access to care through expanded clinic networks and hospital affiliations, along with enhanced care quality and efficiency from new technologies and service offerings.
• Customers (Employers for IIP): Benefit from expanded and diversified injury prevention services, including new testing capabilities, potentially leading to improved workplace safety and reduced injury costs.
• Creditors: The strong balance sheet, effective debt management (fixed interest rate on term loan), and robust cash flow generation indicate a low credit risk profile.

Next Steps

• Continue rollout of ambient listening documentation support across the facility network.
• Implement semi-virtualization of front desk and intake operations.
• Expand cash-based programs, building on initial traction from 2025.
• Press forward with remote therapeutic monitoring, leveraging CMS changes effective in 2026.
• Continue the pursuit of large market strategic hospital alliances, building on recent wins.
• Engage in ongoing de novo and acquisition-related development in both physical therapy and injury prevention segments for 2026.
• Phase-in the two recently announced hospital affiliation agreements starting mid-2026, with full implementation expected by year-end 2026.
• Continue the implementation of the new enterprise-wide financial and human resources system, targeting a January 1, 2027 go-live.

Key Dates

Recommendation

The company delivered exceptional financial results in 2025, significantly growing adjusted EBITDA and revenue despite industry headwinds. The strategic announcement of two major hospital affiliations, projected to add substantial EBITDA by 2027, provides a clear and compelling growth trajectory. Coupled with effective cost management, record patient volumes, and a strong balance sheet, these factors indicate a robust outlook and significant upside potential, making it a strong buy for seasoned investors.

Keywords

Physical therapy, Injury prevention, Healthcare services, Outpatient clinics, EBITDA growth, Hospital affiliations, Acquisitions, Medicare rates, Financial performance, USPH, Corporate strategy